在剖腹产过程中使用 ergometrine 后的 Takotsubo 心肌病
Louise Makarious1, Prayatna Shetty2, David Tanous3
1Westmead Hospital Women's and Newborn Health Department, Westmead, New South Wales, Australia louise.makarious@health.nsw.gov.au.
BMJ case reports
|December 23, 2025
概括
在没有先前心脏病的妇女中,用于产后出血的厄戈米特林可以导致塔科苏博心肌病 (TTCM) 或逆转TTCM. 症状在13天内消失,突出了需要谨慎使用 ergometrine 的必要性.
科学领域:
- 心脏病学 心脏病学
- 产科和妇科 产科和妇科
- 药理学 药理学是指药理学的学科.
背景情况:
- 产后出血是导致产妇死亡的主要原因之一.
- 埃尔戈米特林通常用于管理子宫缩和控制产后出血.
- 厄戈米特林的心血管并发症很少见,但很严重.
研究的目的:
- 报告Takotsubo心肌病变 (TTCM) 的病例,并在施用 ergometrine 后逆转TTCM.
- 为了突出与产后期 ergometrine 相关的潜在心脏风险.
- 强调在没有先前心血管病史的妇女中明智使用人体仪表的重要性.
主要方法:
- 一系列案例报告了三个产后妇女,她们患上了心血管损害.
- 胸外回声图 (TTE) 用于评估左心室 (LV) 缩功能.
- 临床监测和随访,包括连续TTE和药物审查.
主要成果:
- 所有三个患者在产后出血时使用 ergometrine 后都出现了 TTCM 或逆 TTCM.
- 在最初的TTE中观察到明显受损的LV缩功能.
- 在13天内完全恢复LV喷射分数,并在6个月内停止服用心力衰竭药物.
结论:
- 即使在没有心血管风险因素的妇女中,厄戈米特林也可以加速TTCM/逆转TTCM.
- 这种TTCM不同于周周心肌病,通常恢复速度更快.
- 在管理产后出血时,需要仔细考虑和明智地使用厄戈美特林.
相关概念视频
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
251
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
251
01:26Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
360
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
360
01:25Cardiomyopathy I: Introduction and Classification
471
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
471
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
01:26Cardiac Catheterization IV: Nursing Management
602
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
602